Menu Search
Equities

Clorox Co

CLX:NYQ

Clorox Co

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)165.16
  • Today's Change2.39 / 1.47%
  • Shares traded1.28m
  • 1 Year change+25.19%
  • Beta0.4056
Data delayed at least 15 minutes, as of Nov 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy1
Outperform2
Hold14
Sell5
Strong Sell0

Share price forecast in USD

The 19 analysts offering 12 month price targets for Clorox Co have a median target of 162.12, with a high estimate of 188.00 and a low estimate of 139.00. The median estimate represents a -1.84% decrease from the last price of 165.16.
High13.8%188.00
Med-1.8%162.12
Low-15.8%139.00

Dividends in USD

In 2024, Clorox Co reported a dividend of 4.80 USD, which represents a 1.69% increase over last year. The 14 analysts covering the company expect dividends of 4.94 USD for the upcoming fiscal year, an increase of 2.81%.
Div growth (TTM)1.69%
More ▼

Earnings history & estimates in USD

On Oct 30, 2024, Clorox Co reported 1st quarter 2025 earnings of 1.86 per share. This result exceeded the 1.40 consensus of the 14 analysts covering the company and exceeded last year's 1st quarter results by 1.37.
The next earnings announcement is expected on Jan 30, 2025.
Average growth rate+82.15%
Clorox Co reported annual 2024 earnings of 6.17 per share on Aug 01, 2024.
Average growth rate+0.11%
More ▼

Revenue history & estimates in USD

The Clorox Company had 1st quarter 2025 revenues of 1.76bn. This bettered the 1.65bn consensus of the 11 analysts covering the company. This was 27.13% above the prior year's 1st quarter results.
Average growth rate+8.06%
The Clorox Company had revenues for the full year 2024 of 7.09bn. This was 4.01% below the prior year's results.
Average growth rate+1.50%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.